Astrana Health (ASTH) FY2019 results: revenue $561 million, up 7.8% on the year
Astrana Health, Inc. (ASTH) reported revenue of $561 million for fiscal 2019, the year ended 31 December 2019, up 7.8% on the year before. Net income was $14 million, up 30.3%, and diluted earnings per share $0.39. The figures are the company's own, from the 10-K it filed with the SEC on 16 March 2020.
Revenue
$561 million
+7.8% on the year
FY2016FY2019
Operating margin
5.8%
17.0% a year earlier
FY2016FY2019
Net income
$14 million
+30.3% on the year
FY2016FY2019
Diluted EPS
$0.39
+34.5% on the year
FY2016FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
561
520
356
+7.8%
Cost of revenue
468
361
273
+29.5%
Gross profit
92.8
159
82.9
-41.5%
Gross margin
16.6%
30.5%
23.3%
Operating income
32.4
88.4
35.1
-63.3%
Operating margin
5.8%
17.0%
9.9%
Interest expense
4.7
0.6
0.1
+744.4%
Pre-tax income
25.8
82.6
49.7
-68.7%
Income tax
8.2
22.4
3.9
-63.5%
Effective tax rate
31.6%
27.1%
7.8%
Net income
14.1
10.8
25.8
+30.3%
Net margin
2.5%
2.1%
7.2%
Diluted EPS
$0.39
$0.29
$0.90
+34.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
13.7
25.5
51.9
-46.4%
Capital expenditure
1.0
1.2
2.1
-11.0%
Free cash flow
12.6
24.3
49.8
-48.1%
Free cash flow margin
2.3%
4.7%
14.0%
Cash from investing
-181
-25.2
26.7
Cash from financing
163
-11.2
-15.0
Depreciation and amortisation
18.3
19.3
19.1
-5.3%
Share-based compensation
1.5
1.4
2.7
+7.3%
Buybacks
7.6
5.0
3.2
+50.0%
Dividends paid
61.7
17.8
10.4
+247.5%
Diluted shares, weighted
36m
38m
29m
-4.0%
Shares outstanding at period end
36m
35m
32m
+3.8%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
192
181
160
+6.1%
Non-controlling interest
0.8
1.0
4.2
-21.2%
Redeemable equity
169
225
172
-25.1%
Debt
242
0.0
0.5
Operating lease liabilities
11.4
0.0
n/a
Finance lease liabilities
0.4
0.5
n/a
-19.7%
Other liabilities
114
106
154
+7.9%
Total liabilities and equity
729
513
491
+42.0%
Fixed assets
n/a
12.7
13.8
Goodwill
239
186
190
+28.4%
Intangible assets
103
86.9
104
+18.6%
Investments
117
1.1
1.1
+10,239.7%
Cash and equivalents
103
107
99.7
-3.5%
Receivables
11.0
7.7
7.6
+42.3%
Other assets
156
112
74.9
+39.9%
Total assets
729
513
491
+42.0%
10-K for the year ended 31 December 2019, filed 16 March 2020: the filing.